File Name
-
..——
-
Safaris_et_al_Stay-at-home_policy_is_a_case_of_exception_fallacy_an_internet-based_ecological_study_(Nature_magazine)_Mar_2021—2021-03-14 16:19:171743-422X-2-69-Chloroquine is a potent inhibitor of SARS coronavirus infection and spread-Vincent-et al (Virology Journal August 2005).pdf2.44MB2020-05-11 01:37:06A_Double-Inactivated_Severe_Acute_Respiratory_Syndrome_Coronavirus_Vaccine_Provides_Incomplete_Protection_in_Mice_Bolles, et_al_[Journal_of_Virology_2011]_zjv12201.pdf6.79MB2020-01-31 16:33:31A_SARS-like_cluster_of_circulating_bat_coronaviruses_shows_potential_for_human_emergence_(Zhengli-Shi_et_al_Nov_2015)_Nature_Medicine_article_nm.3985.pdf0.97MB2020-10-08 11:54:41A_guideline_to_limit_indoor_airborne_transmission_of_COVID-19_(Bazant_+_Bush)_PNAS_Apr_2021.pdf1.44MB2021-04-26 14:04:27A_pneumonia_outbreak_associated_with_a_new_cornavirus_of_probable_bat_origin_Zhou_et_al_s41586-020-2012-7.pdf10.34MB2020-05-24 13:42:30A_scoping_review_of_the_pathophysiology_of_COVID-19_(IJIP)_Marik_et_al_September_2021.pdf1.41MB2021-09-30 06:21:06Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (Neeltje van Doremalen et al) - March 2020.pdf667.78KB2020-03-13 09:36:02American_attitudes_toward_the_Germ_Theory_of_Disease.pdf1.82MB2021-02-15 11:00:15Analysis_of_therapeutic_targets_for_SARS-CoV-2_and_discovery_of_potential_drugs_by_computational_methods_(Wu, Canrong et al)_Feb_20201-s2.0-S2211383520302999-main.pdf39.72MB2020-03-09 11:38:23Assessing_mandatory_stay_at_home_orders_and_business_closure_effects_on_the_spread_of_Covid-19_(Bendavid_et-al).pdf9.15MB2021-01-11 00:19:36Assessing_the_Age_Specificity_of_Infection_Fatality_Rates_for_COVID-19_(Levin_et_al)_Oct_2020_2020.07.23.20160895v6.full.pdf636.98KB2020-10-13 10:51:52Bonavero_Reports_series_Human_Rights_and_Covid-19_No.3_2020_(May_2020).pdf1.16MB2021-02-04 22:40:16Brain_damage_of_patients_with_COVID-19_(NIH_article)_retrieved_Jan_26_2021.pdf136.81KB2021-01-26 18:44:24COVID-19_Autoantibodies_(McGarty_(MIT)).pdf1.64MB2021-02-10 13:10:31COVID-19_Data_Collection_Comorbidity_and_Federal_Law_A_Historical_Retrospective_Henry_Ealy_et_al_(IPAH_PHPI_paper_Oct_2020).pdf2.34MB2021-06-05 11:46:37CT_differential_diagnosis_of_COVID-19_and_non-COVID-19_in_symptomatic_suspects-a_practical_scoring_method_(Luo_et_al)_BMC_Pulmonary_Medicine_2020.pdf1.82MB2021-04-18 09:45:02Calcifediol_Treatment_and_COVID-19_Related_Outcomes_(Vitamin_D)_Nogues_et_al_SSRN-id3771318_Lancet_Jan_2021_.pdf665.56KB2021-02-13 21:14:45Canceling_the_Spike_Protein_Striking_Visual_Evidence_Thomas_E_Levy_MD_Orthomolecular.Org_2021-10-18.pdf531.78KB2021-10-30 20:09:56Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated- Te et al., 2012_pone.0035421.pdf1.26MB2020-01-31 16:29:19Characteristics_and_risk_factors_for_COVID-19_diagnosis_and_adverse_outcomes_in_Mexico-an_analysis_of_89756_laboratory�confirmed_cases-Giannouchos, 2020.06.04.pdf141.54KB2021-04-22 11:56:42China_ Vaccine Law Passed _ Global Legal Monitor.pdf126.07KB2020-02-18 12:11:40Chloroquine_and_hydroxychloroquine_as_available_weapons_to_fight_COVID-19_(Colson_et_al_Feb_2020)1-s2.0-S0924857920300820-main.pdf693.96KB2020-03-06 13:50:28Community_and_Close__Contact-Exposures_Associated_with_COVID-19_Among_Symptomatic_Adults_≥18_Years_in_11_ Outpatient_HC_Facilities_US_July_2020_(CDC_report_re_facemasks).pdf2.04MB2020-10-13 10:54:59Comparison_of_mortality_associated_with_respiratory_viral_infections_December_2019_March_2020_with_previous_year_in_Southeastern_France_(Giraud-Gatineau_et_al)_May_2020.pdf711.26KB2021-02-15 10:45:44Comprehensive_analysis_of_T-cell-immunodominance_and_immunoprevalence_of_SARS-CoV-2_epitopes_in_COVID-19_cases.pdf9.01MB2021-02-09 12:54:36Correlation_between_Non-Polio_Acute_Flaccid_Paralysis_Rates_with_Pulse_Polio_Frequency_in_India_(Dhiman et al)_Aug_2018_ijerph-15-01755.pdf765.95KB2020-08-21 12:42:04Covid-19_Mortality_A_Matter_of_Vulnerability_Among_Nations_Facing_Limited_Margins_of_Adaptation_(Quentin De Larochelambert_et_al)_Nov_2020.pdf4.54MB2021-01-06 23:15:42Covid-19_modelling_has_failed_Ioannidis et al (Elsevier).pdf3.09MB2020-10-14 10:11:42D-dimer_as_a_biomarker_for_disease_severity_and_mortality_in_COVID-19_patients - a_case_control_study_Journal_of_Intensive_Care_(Yao_et_al)_July_2020.pdf2.01MB2021-01-15 22:38:42Do_many_people_have_pre-existing_immunity_(Doshi)_Sep_2020_bmj.m3563.full.pdf559.17KB2020-10-20 13:56:11Docs4OpenDebate_Open_Letter.pdf179.75KB2020-09-21 17:15:33Dynamic Change of COVID-19 Seroprevalence among Asymptomatic Population in Tokyo during the Second Wave - Sawako Hibino et al (Sept 2020) 2020.09.21.20198796v1.full.pdf178.84KB2020-09-24 09:53:13ED_Date_Analysis_from_unknown_NHS_Trust_John_Dee_research_September_2021.pdf246.33KB2021-09-30 13:50:53Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis - Risch2020.pdf614.30KB2020-08-03 11:55:52Early_viral_clearance_among_Covid-19_patients_when_gargling_with_Povidone-Iodine_(Mohamed_et_al)_2020.09.07.20180448v1.full.pdf203.32KB2020-10-26 10:56:57Effect_of_calcifediol_treatment_best_available_therapy_vs_best_available_therapy_on_ICU_admission_+_mortality_among_patients_ hospitalized_for_COVID-19_A_pilot_Castillo_Oct_2020.pdf1.01MB2020-10-08 14:22:37Effect_of_hydroxychloroquine_with_or_without_azithromycin_on_the_mortality_of_COVID-19_patients_by_Fiolet_et_al-Sep_2020_1-s2.0-S1198743X20306017-main.pdf258.28KB2020-10-08 15:04:55Effects_of_non-pharmaceutical_interventions_on_COVID-19_(Chin-et-el)-2020.07.22.20160341v3.full.pdf5.66MB2020-12-28 16:37:30Elevated_Plasmin(ogen)_as_a_common_Risk_Factor_for_COVID-19_Susceptibility_Hong-Lang_et_al_physrev.00013.2020 (Physiology Journal -Mar 2020).pdf868.79KB2020-05-24 11:54:46Endothelial_cell_infection_and_endothelitis_in_Covid-19 (Lancet)_Apr_2020.pdf409.40KB2020-05-13 16:26:24Evaluating_the_effects_of_shelter-in-place_policies_during_the_COVID-19_pandemic_(Berry_et_al)_PNAS_April_13_2021.pdf802.55KB2021-05-03 15:26:51Evaluating_the_number_of_unvaccinated_people_needed_to_exclude_to_prevent_SARS-CoV-2_transmissions_(Prosser_et_al)_December_2021-2021.12.08.21267162v1.full.pdf870.77KB2021-12-12 14:42:39FLCCC_Alliance_An_overview_of_the_MATH+_and_I-MASK+_Protocols-A_Guide_to_the_Management_of_COVID-19.pdf3.39MB2020-12-10 14:12:40Figure (1).ppt289.00KB2020-10-15 11:06:40Figure (2).ppt392.50KB2020-10-15 11:06:57Figure (3).ppt268.50KB2020-10-15 11:16:07Figure.ppt148.50KB2020-10-15 11:06:20First_Do_No_Harm_Us_for_Them_open_letter_to_UK_Govt_from_multiple_Health_Professionals_Nov_2020.pdf233.95KB2020-11-08 11:29:25First_case_of_postmortem_study_in_a_patient_vaccinated_against_SARS-CoV-2_(Hansen_et_al)_April_2021.pdf1.86MB2021-06-18 13:16:10Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry_Follis_et_al_2006.pdf721.16KB2020-05-24 14:00:43Furin_a_potential_therapeutic_target_for_COVID-19_Canrong WU_et_al_202002.00062v1.pdf2.84MB2020-05-24 12:17:24Hansen_paper_Figure_1_(autopsy_paper).jpg273.47KB2021-06-18 13:10:49Household_Transmission_of_SARS-CoV-2_A_Systematic_Review_and_Meta-analysis_(Madewell_et_al)_JAMA_Network_Open_2020-madewell_2020_oi_200987_1607354087.12032.pdf1.42MB2021-02-13 23:16:48INFERR~1.PDF4.56MB2021-04-14 17:46:47Identification_of_the_highly_infective_genomic_composition_of_SARS-CoV-2_RNA_(Nicola_Bidoli_Thread_Reader_App)_Sep_2021.pdf971.05KB2021-09-20 10:01:13Immunization_with_SARS_Coronavirus_Vaccines_Leads_to_Pulmonary_Immunopathology_on_Challenge_with_the_SARS_Virus_(Chien-Te Tseng et al - April 2012)(pone.0035421).pdf1.26MB2020-02-18 12:09:00In_Vitro_Antiviral_Activity_and_Projection_of_Optimized_Dosing_Design_of_Hydroxychloroquine_for_the_Treatment_of_Severe_Acute_Respiratory_Syndrome_Cov_2_Yao_et_al_Mar_2020.pdf1.58MB2020-03-31 15:30:47Infection_fatality_rate-of_Covid-19_inferred_from_seroprevalence_data_(Bulletin_of_the_WHO)_BLT.20.265892_John_P_A_Ioannidis_pub_Oct_2020.pdf858.21KB2021-01-21 21:13:06JCI_Insight_A_majority_of_uninfected_adults_show_pre-existing_antibody_reactivity_against_SARS-CoV-2_(Majdoubi_et_al)_March_2021.pdf1.72MB2021-03-16 12:11:26Lockdown_Efficacy_Studies_(summary_from_the_HART_Group_2021).pdf74.50KB2021-04-16 18:42:24Low-dose_Hydroxychloroquine_Therapy_and_Mortality_in_Hospitalized_Patients_with_COVID-19_(Catteau et al)_Aug_2020_1-s2.0-S0924857920303423-main.pdf1.14MB2020-08-27 08:27:42MIT_infiltration_paper_2101.07993.pdf23.49MB2021-05-11 06:10:47MSH3_Homology_and_Potential_Recombination_Link_to_SARS-CoV-2_Furin_Cleavage_Site_(Frontiers_in_Virology)_Ambati_et_al_February_2022.pdf563.78KB2022-02-25 14:23:29Minimal_transmission_of_SARS-CoV-2_from_paediatric_COVID-19_cases_in_primary_schools_Norway-Brandal_et_al_eurosurv-26-1-1.pdf219.72KB2021-01-31 10:13:53Mutant_Measles_morbillivirus_strain_MeVvac2-SARS2-S(H)_complete_genom - Nucleotide - NCBI.pdf344.07KB2021-08-24 10:52:25NONPHA~1.PDF875.89KB2021-01-28 21:43:04Need_for_assessing_the_inhalation_of_micro(nano)plastic_debris_shed_from_masks_respirators_and_home-made_face_coverings_during_the_COVID-19_pandemic_(Han_+_He)_July_2020.pdf637.09KB2021-02-27 12:45:55Negligible_impact_of_SARS-CoV-2_variants_on_CD4+_and_CD8+_T_cell_reactivity_in_COVID-19_exposed_donors_and_vaccinees_(Tarke_et-al)_Feb_27_2021-2021.02.27.433180v1.full.pdf2.11MB2021-03-02 16:22:13Neuropilin-1_facilitates_SARS-CoV-2_entry_infectivity_(Cantuti-Castelvetri_et_al)_Oct_2020_science.abd2985.full.pdf2.65MB2020-10-25 10:38:59New_Quality-Control_investigations_on_Vaccines-micro-and_nanocontamination-IJVV-04-00072-2017.pdf0.98MB2021-03-03 20:10:45No_evidence_for_increased_transmissibility_from_recurrent_mutations_in_SARS-CoV-2_(Van Dorp et al - Nov 2020).pdf4.53MB2020-12-28 18:46:48Nosocomial_infections_among_patients_with_COVID-19_SARS_and_MERS_a_rapid_review_and_meta-analysis_(Zhou_et_al)_April_2020-atm-08-10-629.pdf2.12MB2021-03-02 13:49:15Omicron_infection_enhances_neutralizing_immunity_against_the_Delta_variant_(pre-print)_MEDRXIV-2021-268439v1-Sigal_Khan_et_al_December_2021.pdf449.59KB2021-12-28 09:42:45Pathogenic_antibodies_induced_by_spike_proteins_of_COVID-19_and_SARS-CoV-2_viruses_(Wang_et_al)_June_2021.pdf1.75MB2021-10-14 05:42:20Pathogenic_priming_likely_contributes_to_serious_and_critical_illness_and_mortality_in_COVID-19_via_autoimmunity_Journal_of_Translational_Autoimmunity_April_2020_James_Lyons-Weiler.pdf213.94KB2021-03-25 11:30:28Phylogenetic network analysis of SARS-CoV-2 genomes_Forster et al March 30 2020_2004999117.full.pdf512.63KB2020-04-13 01:36:11Post-lockdown_SARS-CoV-2_nucleic_acid_screening_in_nearly_ten_million_residents_of_Wuhan_China_(Nature_Cao_et_al)_Nov_2020.pdf1.05MB2020-11-25 11:27:02Pre-existing_polymerase_specific_T_cells_expand_in_abortive_seronegative_SARS-CoV-2_infection_(Swadling_et_al)_June_2021 2021.06.26.21259239v1.full.pdf7.07MB2021-07-02 14:50:16Pre-existing_polymerase_specific_T_cells_expand_in_abortive_seronegative_SARS-CoV-2_infection_(Swadling_et_al)_June_2021 2021.06.26.21259239v1.full_compressed.pdf2.17MB2021-07-02 14:56:04Predominance_of_antibody-resistant_SARS-CoV-2_variants_in_vaccine_breakthrough_cases_from_the_San_Francisco_Bay_Area_California_(Servellita_et_al)_Aog_2021.pdf941.67KB2021-10-04 12:36:49Preventable_deaths_from_SARS-CoV-2_in_England_and_Wales_a_systematic_analysis_of_coroners_case_reports_(Swift_Heneghan_et_al)_.pdf429.05KB2021-07-27 12:20:13Prior_SARS-CoV-2_infection_is_associated_with_protection_against_symptomatic_reinfection_Hanratti_et_al_Dec_2020-PIIS0163445320307817.pdf735.56KB2021-01-05 22:57:35Prior_immunization_with_severe_acute_respiratory_syndrome_(SARS)-associated_coronavirus_(SARS-CoV)_yasui,et_al J Immunol.181_6337-48.pdf1.38MB2020-01-31 16:36:42Protection_and_waning_of_natural_and_hybrid_COVID-19_immunity_(Goldberg_et_al)_December_2021-2021.12.04.21267114v1.full.pdf817.49KB2021-12-11 17:33:49Public_Health_&_Medical_Professionals_for_Transparancy_vs_FDA_001-Complaint_101021.pdf1.05MB2021-10-13 13:50:43Public_Health_Lessons_Learned_From_Biases_in_Coronavirus_Mortality_Overestimation_Ronald_B_Brown_PhD.pdf335.44KB2021-01-24 16:05:59Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Luca Ferretti et al 2020-science.abb6936.full.pdf1.20MB2020-05-27 00:32:04RNA_Recombination_In_Vivo_in_the_Absence_of_Viral_Replication_Gallei_et_al_June_2004.pdf1.98MB2021-07-29 12:12:45Reactivation_of_IgA_vasculitis_after_COVID-19_vaccination_(Lancet_correspondence)_2021-07-06.pdf46.32KB2021-10-08 11:09:02Reasoning_of_spike_glycoproteins_being_more_vulnerable_to_mutations_Wu_2004.pdf498.21KB2021-10-08 09:25:12Reduced_prevalence_of_SARS-CoV-2_infection_in_ABO_blood_group_O_(ASH_Journal_Blood_Advances_Oct_2020).pdf644.23KB2020-10-15 11:11:56Reduced_prevalence_supplement_advancesadv2020002657-suppl1.pdf231.81KB2020-10-15 11:17:31Request-for-Expedited-Federal-Investigation-Into-Scientific-Fraud-in-COVID-19-Public-Health-Policies_Jan_10_2021_(with_signatories).pdf774.99KB2021-01-10 21:58:18Resurgence_of_SARS-CoV-2_Infection_in_a_Highly_Vaccinated_Health_System_Workforce_Keehner_+_Horton_NEJM_correspondence_September_02_2021.pdf372.26KB2021-09-02 15:07:14Return_of_the_Coronavirus_2019-nCoV_(Gralinski_and_Menachery_Jan_2020)viruses-12-00135-v2.pdf503.27KB2020-02-18 12:29:20Revealing_the_role_of_CD4+_T_cells_in_viral_immunity_(Sant_+_McMichael_-J. Exp. Med. 2012 Vol. 209 No. 8 1391-1395)-JEM_20121517.pdf1.17MB2020-09-23 13:35:40Reverse-transcribed_SARS-CoV-2_RNA_can_integrate_into_the_genome_of_cultured_human_cells_and_can_be_expressed_in_patient-derived_tissues_(Zhang_et_al)_April_2021.pdf921.56KB2021-10-07 10:22:44Reverse_genetics_with_a_full-length_infectious_cDNA_of_severe_acute_respiratory_syndrome_coronavirus_(Yount_+_Baric_et_al)_2003-12995.full.pdf655.12KB2021-04-28 14:11:46Review_of_the_Emerging_Evidence_Demonstrating_the_Efficacy_of_Ivermectin_in_the_Prophylaxis_and_Treatment_of_COVID-19_Kory_et_al_Dec_08_2020.pdf2.09MB2020-12-10 14:13:12Risk_of_hospital_admission_with_Covid-19_among_teachers_compared_with_healthcare_workers_and_other_adults_of_working_age_in_Scotland_Fenton_et_al_BMJ_Sep_2021.pdf556.93KB2021-09-02 11:20:36Risk_of_mortality_in_patients_infected_with_SARS-CoV-2_variant_of_concern_202012_1 - matched_cohort_study_(Challen_et_al)_Feb_2021-bmj.n579.full.pdf657.22KB2021-03-10 12:53:24Robust_T cell_immunity_in_convalescent_individuals_with_asymptomatic_or_mild_Covid-19_(Sekine et al August 2020).pdf8.27MB2020-08-16 20:44:41SARS-CoV-2 Spike Protein Impairs Endothelial_Function_via_Downregulation_of_ACE-2_(Lei_et_al)_April_2021.pdf3.01MB2021-05-04 18:58:26SARS-CoV-2 infection_induces_long_lived_bone_marrow_plasma_cells_in_humans_(Nature_magazine)-Taylor_et_al_May_14_2021.pdf6.57MB2021-06-02 13:00:43SARS-CoV-2_RNA_reverse-transcribed_and_integrated_into_the_human_genome_Zhang_et_al_Dec_2020.pdf3.68MB2021-02-27 16:27:17SARS-CoV-2_SARS-CoV_MERS-CoV_viral_load_dynamics_duration_of_viral_shedding_Cevik_et_al_(Lancet_Nov_2020)_PIIS2666524720301725.pdf694.16KB2020-11-25 11:23:40SARS-CoV-2_direct_cardiac_damage_through_spike-mediated_cardiomyocyte_fusion_Schneider_et_al_2021.pdf298.30KB2021-09-01 11:26:59SARS-CoV-2_elicits_robust_adaptive_immune_responses_regardless_of_disease_severity_(Nielsen_et_al)_May_2021.pdf2.29MB2021-06-10 10:32:23SARS-CoV-2_infects_lung_epithelial_cells_and_induces_senescence_and_an_inflammatory_response_in_patients_with_severe_COVID-19_(Evangelou_et_al)_May_2021-2021.01.02.424917v2.full.pdf5.81MB2021-08-17 14:57:18SARS-CoV-2_spike_protein_S1_induces_fibrin(ogen)_resistant_to_fibrinolysis-Implications_for_microclot_formation_in_COVID-19_(Lize M. Grobbelaar_et_al)_March_2021.pdf2.28MB2021-06-04 11:27:38Serologic_testing_of_US_ blood_donations_to_identify_SARS-CoV-2_reactive_antibodies_Basavaraju_et-al-ciaa1785_(Jan_2021).pdf708.93KB2021-01-03 00:18:41Serum_levels_of_Vitamin_C-and_Vitamin_D_in_a_cohort_of_critically_ill_COVID-19_patients_of_a_North_American_Community_Hospital_ICU_in_May_2020_Pilot_ Study_(Arvinte_et_al)_Sep_2020_1-s2.0-S2590098620300518-main.pdf903.45KB2020-10-08 14:29:50Severe_Acute_Respiratory_Syndrome_Coronavirus_Infection_Causes_Neuronal_Death_in_the_Absence_of_Encephalitis_in_Mice_Transgenic_for_Human_ACE2_(Netland et al - May 2008)_0737-08.pdf1.46MB2020-02-25 13:31:03Severe_COVID-19_ A_multifaceted_viral_vasculopathy_syndrome_(Magro_et_al)) - Science_Direct_Feb_2021.pdf188.86KB2021-06-21 09:40:11Single-cell_RNA_expression_profiling_of_ACE2_the_putative_receptor_of_Wuhan_2019-nCov_Zhao,Y_Zhao,Z_Wang,Y_Zhou,Y,Yu Ma,_Wei Zu [Paper - abstract 2020, Jan)_2020.01.26.919985v1.full.pdf726.90KB2020-01-30 14:05:20Smoking, vaping and hospitalization for COVID-19 - Article (Preprint v13) _ Qeios.pdf3.74MB2020-04-09 22:55:17Staphylococcal_Enterotoxin_B_(SEB)_as_a_Biological_Weapon_Recognition_Management_and_Surveillance_of_Staphylococcal_Enterotoxin_(Ahanotu_et_al)_Applied_Biosafety_ABSA_2006.pdf131.99KB2021-12-11 11:55:56Superantigenic_character_of_an_insert_unique_to_SARS-CoV-2_spike_supported_by_skewed_TCR_repertoire_in_patients_with_hyperinflammation_(Cheng_et_al)_May_2020-SEB_related.pdf2.51MB2021-12-11 11:58:08Targets_of_T_Cell_Responses_to_SARS-CoV-2_Coronavirus_in_Humans_with_COVID-19_Disease_and_Unexposed_Individuals_Grifoni_et_al_June_2020 - ScienceDirect.pdf276.22KB2021-04-07 10:55:58Temperature_and_latitude_analysis_to_predict_potential_spread_and_seasonality_for_COVID-19_(Sajadi_et_al)_Mar_2020_SSRN-id3550308.pdf2.18MB2020-03-14 19:33:59The _role_of_vitamin_D_in_the_health_of_Hispanic_adults_with_diabetes - PubMed_(Castro_+_Penckhofer - abstract).pdf95.48KB2021-01-15 22:52:06The_Association_of_ABO_blood_group_with_indices_of_severity_and_multiorgan_dysfunction_in_COVID-19_(ASH_Journal_Blood_Advances_Oct_2020).pdf899.96KB2020-10-15 11:13:24The_CCP's_Global_Lockdown_Fraud _ Jan, 2021 _ Medium_Open_Letter_(Hoar_Dolan_et-al).pdf1.46MB2021-01-10 23:04:36The_Treatment_of_Viral_Diseases-Has_the_Truth_Been_Suppressed_for_Decades_Journal_APS_Vol_25_No_3_Fall_2020_Dr.Lee_Merritt.pdf58.03KB2021-04-08 16:56:42The_possible_origins_of_2019-nCoV_coronavirus_Xiao_B_Xiao_Lei_Feb_2020.pdf550.96KB2020-02-21 15:35:58Transmission_of_SARS-CoV-2_Delta_variant_among_vaccinated_healthcare_workers_Vietnam_SSRN-id3897733_Nguyen_et_al.pdf1.37MB2021-08-24 08:30:25Ultrapotent_antibodies_against_diverse_and_highly_transmissable_SARS-CoV-2_variants_(Wang_et_al)_Science_abh1766_July_2021.pdf12.29MB2021-07-13 13:31:54Uncanny_similarity_of_unique_inserts_in_the_2019-nCoV_spike_protein_to_HIV-1_gp120_and_Gag_Pradhan_et_al_2020.01.30.927871v1.full.pdf3.24MB2020-02-02 00:27:00Upper_respiratory_tract_SARS-CoV-2_RNA_loads_in_symptomatic_and_asymptomatic_children_and_adults_(Costa_et_al)_March_2021.pdf3.02MB2021-03-05 14:56:42Viral_cultures_for_COVID-19_infectious_potential_assessment � a_systematic_review - Jefferson-T_et-al_Dec_2020 ciaa1764.pdf0.99MB2020-12-07 13:26:26Vitamin_D_status_in_hospitalized_patients_with_SARS-CoV-2_infection_(Hernandez_et_al)_Oct_2020_dgaa733.pdf1.04MB2020-10-28 11:19:05Was_R_less_than_1_before_the_English_lockdowns_On_modelling_mechanistic_detail_causality_and_inference_about_Covid-19_(Wood_+_Wit)_March_15_2021-2021.02.03.21251112v2.full.pdf1.06MB2021-04-21 11:14:11Zinc_Ionophore_activity_of_Quercetin_and_Epigallcatechin-galleate_dabbagh-bazarbachi_2014.pdf5.52MB2020-03-31 15:34:37[IJID]_Early_Hydroxychloroquine_but_not_Chloroquine_use_reduces_ICU_admission_in_COVID-19_patients_(Lammers_et_al)_Sep_20201-s2.0-S1201971220321755-main.pdf2.88MB2020-10-08 14:32:53[LANCET]_Are_patients_with_hypertension_and_diabetes_melitus_at_increased_risk_for_COVID-19_infection_(Fang_et_al)_Mar_2020_PIIS2213260020301168.pdf411.22KB2020-03-13 16:11:48[LANCET]_Clinical_features_of_patients_infected_with_2019_novel_coronavirus_in_Wuhan_China_Huang_et_al_(Jan 2020)_PIIS0140673620301835.pdf1.23MB2020-02-01 18:52:24[LANCET]_Country_level_analysis_of_Covid-19_measures_(Lancet)_Aug_2020_PIIS258953702030208X.pdf456.77KB2020-10-14 10:16:41[LANCET]_Nowcasting_and_forecasting_the_potential_domestic_and_international_spread_of_the_2019-nCoV_outbreak_originating_in_Wuhan_China - a_modelling_study_(Wu, Joseph T_et_al-Jan 2020)_Lancet-nCov2019-model.pdf2.62MB2020-02-19 14:12:56[Letter]_A_word_of_caution_in_interpreting_COVID-19_diagnostics_tests_JMV-9999-na.pdf295.96KB2021-02-15 14:50:59[Letter]_Covid-19_does_not_lead_to_a_typical_ARDS_ATS_American_Thoracic_Society_journal_(Luciano_ Gattinoni_et_al_Mar_30_2020)_rccm.202003-0817le.pdf169.10KB2020-04-07 20:55:40[Letter]_WDA_World_Doctors_Alliance_Open_Letter_Nov_2020.pdf154.12KB2020-11-05 17:44:58[PLOS_ONE]_SARS-CoV-2_positivity_rates_associated_with_circulating_25-hydroxyvitamin_D_levels_Harvey W. Kaufman_et_al_(Sep_2020]_journal.pone.0239252.pdf1.32MB2020-10-08 13:19:32[PUBMED]_Chloroquine_phosphate_has_shown_apparent_efficacy_in_treatment_of_COVID-19_associated_pneumonia_in_clinical_studies_Jianjun_Gao_et_al_Feb_2020_14_2020.01047.pdf199.71KB2020-03-20 12:39:15[WILEY]_Potential_Interventions_for_Novel_Coronavirus_in_China_A_Systematic_Review-(Zhang_and_Lui_Feb_2020) Wiley_article_jmv.25707.pdf244.34KB2020-02-26 13:30:40[WILEY]_The_neuroinvasive_potential_of_SARS-CoV2_may_be_at_least_partially_responsible_for_the_respiratory_failure_of_COVID-19_patients_(Li, Yanchao).pdf49.18KB2020-03-06 14:50:43manor-figure_control_spike_protein_from_salk_research_mitochondrial_fragmentation_in_vascular_cells.png834.92KB2021-06-21 10:31:51science - Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Luca Ferretti.ppt459.00KB2020-04-13 12:44:03science_(Neuropilin-1).ppt856.00KB2020-10-25 10:53:40